Medicare Enrolled

Dr. Anita Westafer, M.D.

Family Medicine · Gulf Breeze, FL
Low-engagement
2569 GULF BREEZE PKWY, Gulf Breeze, FL 32563
8509340932
In practice since 2005 (20 years)
NPI: 1417938739 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Westafer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Westafer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Westafer

Dr. Anita Westafer is a family medicine specialist in Gulf Breeze, FL, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Westafer received a total of $1,945 from 24 pharmaceutical and/or device companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Westafer is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice $1,945 industry payments

Industry Payment Transparency

Open Payments through 2019 ↗
$1,945
Total received (2018-2019)
Avg $972/year across 2 years
Top 23% in FL for family medicine
24
Companies
144
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,910 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35 (1.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2019
$656
2018
$1,288

Payments by company (2019)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$269
AstraZeneca Pharmaceuticals LP
$245
Amgen Inc.
$243
Lilly USA, LLC
$134
Astellas Pharma US Inc
$133
Radius Health, Inc.
$129
PFIZER INC.
$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$102
Shire North American Group Inc
$95
GlaxoSmithKline, LLC.
$95
SANOFI-AVENTIS U.S. LLC
$73
Allergan Inc.
$69
AMAG Pharmaceuticals, Inc.
$35
Janssen Pharmaceuticals, Inc
$35
Merck Sharp & Dohme Corporation
$34
Takeda Pharmaceuticals U.S.A., Inc.
$24
Amarin Pharma Inc.
$24
Sunovion Pharmaceuticals Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$15
Genentech USA, Inc.
$14
SANOFI PASTEUR INC.
$14
Sanofi Pasteur Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 38.9% of total payments
Associated products mentioned in payments ›
AJOVY · Aimovig · BEXSERO · BOOSTRIX · BREO · CHANTIX · ELIQUIS · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · INTRAROSA · JANUVIA · LINZESS · LONHALA MAGNAIR · LYRICA · Livalo · MENACTRA · MYDAYIS · MYRBETRIQ · Otovel · Ozempic · PREVNAR - 13 · Prolia · Repatha · SOLIQUA · Saxenda · TOUJEO · TRELEGY ELLIPTA · TRULICITY · Tresiba · Tymlos · VESICARE · VIBERZI · VRAYLAR · VYVANSE · Vascepa · XARELTO · XIFAXAN · XIFIXAN · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a family medicine specialist in Gulf Breeze?
Compare family medicine physicians in the Gulf Breeze area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
272
Per 100K population
140.4
County median income
$88,968
Nearest hospital
GULF BREEZE HOSPITAL
6.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2019
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Westafer is a family medicine specialist, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Westafer receive payments from pharmaceutical companies?
Yes. Dr. Westafer received a total of $1,945 from 24 companies across 144 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Westafer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →